Sen, S. Et Al. 2023. Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment. Multiple Sclerosis and Related Disorders , vol.79 .

Sen, S., Tuncer, A., Terzi, M., BÜNÜL, S. D., Ozen-Acar, P., Altunrende, B., ... ÖZAKBAŞ, S.(2023). Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment. Multiple Sclerosis and Related Disorders , vol.79.

Sen, Sedat Et Al. "Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment," Multiple Sclerosis and Related Disorders , vol.79, 2023

Sen, Sedat Et Al. "Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment." Multiple Sclerosis and Related Disorders , vol.79, 2023

Sen, S. Et Al. (2023) . "Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment." Multiple Sclerosis and Related Disorders , vol.79.

@article{article, author={Sedat Sen Et Al. }, title={Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment}, journal={Multiple Sclerosis and Related Disorders}, year=2023}